A clinical trial of herbal compound MA-305 in patients with mild to moderate hypertension: A Pilot Study.
Phase 3
- Registration Number
- CTRI/2010/091/000418
- Lead Sponsor
- Sh. Anand ShrivastavaChairman & MD,Maharishi Ayurveda Products Pvt. Ltd.,A-14, M.C.I.E., Mathura Road,New Delhi ? 110 044.Phone : 011-26959401, 403.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1.. Patients who are willing to participate in the study.
`2 . Aged 18 to 70 yrs.
`3. Primary hypertensive patients.
`4. Patients with pre hypert ensive ( SBP: 120-130, DBP: 80-89) and
stage 1( SBP:140-159, DBP: 90-99) (According to JNC 7 criteria).
``5. patients with stable blood pressure and with no significant change in their therapy over the last 4 ``weeks prior to entry into the study.
Exclusion Criteria
(a) Patients unwilling to participate.
(b) Pregnancy and breast-feeding.
(c) Concomitant severe diseases.
(d) Uncontrolled hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of study is to evaluate the efficacy and tolerability of herbal compound MA ?305 in patients with mild to moderate hypertension.Timepoint:
- Secondary Outcome Measures
Name Time Method OTimepoint: